24_07_Stream_Banner_01-01 24_07_Stream_Banner_01-01

OUTSOURCED PHARMA RECENT WEBINARS

46:45 GettyImages-821365510_brain

The Importance Of Cognitive And Pharmacodynamic Testing During First-In-Human Trials

22:08 GettyImages-1434627610 lab, manufacturing

CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity

47:08 adare 4-29

3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies

57:29 GettyImages-2193840525-dna-strand-viral-vector-gene-therapy

Harnessing Potential: Innovations And Improvements In Viral Gene Therapy

48:07 Label-Free Whole-Body Pharmacokinetics

Label-Free Whole-Body Pharmacokinetics

40:46 bend spray thumb

Spray Dried Dispersions: Performance, Manufacturability, Stability

CELL AND GENE THERAPY OUTSOURCING

3:33 Comprehensive, Integrated BioServices

Comprehensive, Integrated BioServices

57:29 GettyImages-2193840525-dna-strand-viral-vector-gene-therapy

Harnessing Potential: Innovations And Improvements In Viral Gene Therapy

20:18 FUJI April OPCU CG

FUJIFILM Diosynth Biotechnologies Capacity Update April 2025: Cell & Gene Therapy

24:55 VintaBio April OPCU CG

Vinta Bio Capacity Update April 2025: Cell & Gene Therapy

20:03 Kincell April OPCU CG

Kincell Bio Capacity Update April 2025: Cell & Gene Therapy

22:59 Comprehensive Cell Solutions April OPCU CG

Comprehensive Cell Solutions Capacity Update April 2025: Cell & Gene Therapy

21:31 Miltenyi April OPCU CG

Miltenyi Biotec B.V. & Co. KG Capacity Update April 2025: Cell & Gene Therapy

22:02 Andelyn April OPCU CG

Andelyn Capacity Update April 2025: Cell & Gene Therapy

22:07 SK pharmteco April OPCU CG

SK pharmteco Capacity Update April 2025: Cell & Gene Therapy

23:39 Millipore April OPCU CG

Advancing Cell & Gene Therapies To Patients

More From Cell And Gene Therapy Videos

THE LONZA CHANNEL

44:43 GettyImages-512051390-antibody-antibodies

Rapid Delivery Of Toxicological Study Material: Accelerating Development

57:23 GettyImages-155374807-molecule-molecular

De-Risking Early Phase Micronization With Integrated Solid Form Selection

16:11 lonza jan opcu ff

Lonza Capacity Update January 2025: Fill/Finish

1:01:23 GettyImages-1182436133 scientist, lab, research, oncology

Accelerating Clinical Development: Modern Tools In Process Chemistry

53:38 GettyImages-2017789595 lab, research

Early Preclinical Development: A Successful Transition To cGMP Manufacturing

56:08 GettyImages-2032712798-lab-vaccine-microscope-research-development

Vector Technology For Improved Expression Control Of Biotherapeutic Proteins

21:46 lonza october opcu

Lonza Capacity Update October 2024: Small Molecule

1:00:23 GettyImages-1169928112-patient-doctor-medicine-pill-capsule-tablet-OSD-oral

Enabled Form Selection For Oral Drug Products

More From The Lonza Channel

SMALL MOLECULE OUTSOURCING

46:45 GettyImages-821365510_brain

The Importance Of Cognitive And Pharmacodynamic Testing During First-In-Human Trials

0:30 Welcome to austinpx

AustinPX Site Tour

47:08 adare 4-29

3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies

20:18 Sk pharmteco April OPCU Small Mol

SK pharmteco Capacity Update April 2025: Small Molecule

17:40 Ropack April OPCU Small Mol

Ropack Pharma Solutions Capacity Update April 2025: Small Molecule

21:20 SK pharmteco April OPCU Analytics

SK pharmteco Capacity Update April 2025: Analytical Services

40:46 bend spray thumb

Spray Dried Dispersions: Performance, Manufacturability, Stability

1:58 Douglas CDMO

Douglas CDMO: End-To-End Pharmaceutical Solutions With A Softgel Specialty

1:30 bora future thumb

Bora Pharmaceuticals: A Future Focused CDMO

8:39 Emerging Trends In The CDMO Landscape With Bend Bioscience

Emerging Trends In The CDMO Landscape With Bend Bioscience

More From Small Molecule Videos

BIOLOGIC OUTSOURCING

0:30 Welcome to austinpx

AustinPX Site Tour

22:08 GettyImages-1434627610 lab, manufacturing

CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity

2:31 White Raven's Accelerated Path To GMP Certification Splash

White Raven's Accelerated Path To GMP Certification

3:03 Aseptic Filling Service Solutions: Designed To Help You Gain Speed To Clinic And Market Splash

Service Solutions Designed To Help You Gain Speed To Clinic And Market

14:31 Cambrex April OPCU Small Mol

Cambrex Capacity Update April 2025: Small Molecule

More From Biologic Videos

OUTSOURCED PHARMA CAPACITY UPDATES

14:31 Cambrex April OPCU Small Mol

Cambrex Capacity Update April 2025: Small Molecule

21:07 Bend April OPCU Small Mol

Bend Bioscience Capacity Update April 2025: Small Molecule

20:18 Sk pharmteco April OPCU Small Mol

SK pharmteco Capacity Update April 2025: Small Molecule

17:40 Ropack April OPCU Small Mol

Ropack Pharma Solutions Capacity Update April 2025: Small Molecule

22:36 upperton jan opcu small molecule

Upperton Pharma Solutions Capacity Update January 2025: Small Molecule

24:07 douglas jan opcu small molecule

Douglas CDMO Capacity Update January 2025: Small Molecule

25:39 alcami jan opcu small molecule

Alcami Capacity Update January 2025: Small Molecule

20:04 aji jan opcu small molecule

Ajinomoto Bio-Pharma Services Capacity Update January 2025: Small Molecule

23:08 sk pharmteco october small mol opcu

SK pharmteco Capacity Update October 2024: Small Molecule

22:30 singota october opcu

Singota Solutions Capacity Update October 2024: Small Molecule

20:50 pci october small mol opcu

PCI Pharma Capacity Update October 2024: Small Molecule

21:46 lonza october opcu

Lonza Capacity Update October 2024: Small Molecule

14:15 curia october small mol opcu

Curia Capacity Update October 2024: Small Molecule

22:45 alcami october small mol opcu

Alcami Capacity Update October 2024: Small Molecule

16:31 abbvie october opcu

AbbVie Capacity Update October 2024: Small Molecule

24:25 Douglas CDMO SMDF

Douglas CDMO Capacity Update July 2024: Small Molecule Finished Dosage Form

19:58 Alcami SMDF

Alcami Capacity Update July 2024: Small Molecule Finished Dosage Form

20:00 AustinPx SMDF

AustinPx Capacity Update July 2024: Small Molecule Finished Dosage Form

21:04 Curia SMA

Curia Capacity Update July 2024: Small Molecule APl And HPAPI Development

21:10 AbbVie SMA

AbbVie Capacity Update July 2024: Small Molecule APl And HPAPI Development

OPCU Update Channel

OUTSOURCED PHARMA LIVE!

1:00:23 24_05_OPL_CMC_Webinar_1920x1080

How Can CMC Keep Up With The Rush To The Clinic?

2:54 24_05_OPL_CMC_Webinar_1920x1080_Seg01

Outsourcing Not Plug-And-Play

1:26 24_05_OPL_CMC_Webinar_1920x1080_Seg02

You Need A Gap Analysis Before Outsourcing

3:14 24_05_OPL_CMC_Webinar_1920x1080_Seg03

Speeding Up The Regulatory Side Of Outsourcing

1:15 24_05_OPL_CMC_Webinar_1920x1080_Seg04

Consultants Know: Emerging Biotechs Have Outsourcing "Disconnects"

2:27 24_05_OPL_CMC_Webinar_1920x1080_Seg05

A New Acronym – CBMC? Put "Biology" In CMC? Our Panelists Think Not.

3:51 24_05_OPL_CMC_Webinar_1920x1080_Seg06

When Outsourcing, Get The Right Professionals On Your Internal Team

4:29 24_05_OPL_CMC_Webinar_1920x1080_Seg07

Speed To Clinic, Cost To Get There, And FDA Expectations

2:56 24_05_OPL_CMC_Webinar_1920x1080_Seg08

"Relentless Transparency" Needed Between CDMO And Biotech Customer

7:59 24_05_OPL_CMC_Webinar_1920x1080_Seg09

How Much Can You Actually Rely On Your CDMO?

3:34 24_05_OPL_CMC_Webinar_1920x1080_Seg10

How Much Do You Need To Pay Your CDMOs … And When?

3:39 24_05_OPL_CMC_Webinar_1920x1080_Seg11

Can't Afford A Head Of Clinical And CMC? Think Again

Outsourced Pharma Live Event

THE BUSINESS OF BIOTECH

55:54 24_01_BoB_1280x720_Ep252

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

49:54 24_01_BoB_1280x720_Ep229

Biopolitics With Allan Shaw

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

56:38 24_01_BoB_1280x720_Ep212

Expanding The Proteome with ProFound's John Lepore, M.D.

1:06:39 24_01_BoB_1280x720_Ep211

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

1:08:52 24_01_BoB_1280x720_Ep210

First AI Antibody In Humans with Aulos' Aron Knickerbocker

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

58:06 24_01_BoB_1280x720_Ep208

Topical Ocular Biologics with Claris Bio's Clarke Atwell

1:04:08 24_01_BoB_1280x720_Ep206

True DEI Value in Biopharma with Arcellx's Rami Elghandour

22:57 BoB_Ep204_Ch02

How Daiichi Sankyo Revitalized ADCs

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

26:07 BoB_Ep203_Ch02

How Is Mythic Therapeutics Transforming The ADC Space?

1:04:06 24_01_BoB_1280x720_Ep204

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

12:15 BoB_Ep196_Ch04

What's Next For Ampersand Biomedicines?

The Business of Biotech Channel

THE CELL & GENE PODCAST

17:54 23_12_CGPodcast_1280x720_Ep102

Redefining Heart Failure Treatment with Precision Autologous Cell Therapy with BioCardia's Peter Altman, Ph.D.

28:15 23_12_CGPodcast_1280x720_Ep100

Rethinking CGT Biotech Growth & Investment with Audrey Greenberg

14:53 23_12_CGPodcast_1280x720_Ep99

Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita

34:57 23_12_CGPodcast_1280x720_Ep98

Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar

28:42 23_12_CGPodcast_1280x720_Ep97

CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.

35:38 23_12_CGPodcast_1280x720_Ep96

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

26:49 23_12_CGPodcast_1280x720_Ep95

The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.

24:24 23_12_CGPodcast_1280x720_Ep94

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

14:49 23_12_CGPodcast_1280x720_Ep93

Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

31:14 23_12_CGPodcast_1280x720_Ep91

Inside A Dopamine-Restoring Cell Therapy For PD With BlueRock Therapeutics' Dr. Amit Rakhit

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

22:00 23_12_CGPodcast_1280x720_Ep86

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

29:55 23_12_CGPodcast_1280x720_Ep82

Identifying Drug Development Opportunities For DMD With CureDuchenne

21:01 23_12_CGPodcast_1280x720_Ep81

Tackling 'The Delivery Problem' Of Gene Editing-Based Medicines

31:48 23_12_CGPodcast_1280x720_Ep76

Dr. Bruce Levine on ISCT and the Future of CAR-T

29:39 23_12_CGPodcast_1280x720_Ep74

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

23:08 23_12_CGPodcast_1280x720_Ep73

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

19:37 23_12_CGPodcast_1280x720_Ep72

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

17:17 23_12_CGPodcast_1280x720_Ep71

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

27:31 23_12_CGPodcast_1280x720_Ep70

The Future of Rare Diseases with The Jackson Laboratory's Rare Disease Translational Center's Cat Lutz

20:48 23_12_CGPodcast_1280x720_Ep69

Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead Company's Christopher McDonald

37:17 23_12_CGPodcast_1280x720_Ep68

Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

21:33 23_12_CGPodcast_1280x720_Ep67

Breaking Down Solid Tumors With Triumvira Immunologics' Dr. Paul Lammers

31:59 23_12_CGPodcast_1280x720_Ep66

4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.

The Cell & Gene Podcast Channel